| Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott Jama 324 (8), 782-793, 2020 | 6220 | 2020 |
| Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones ofStaphylococcus aureus MC Enright, NPJ Day, CE Davies, SJ Peacock, BG Spratt Journal of clinical microbiology 38 (3), 1008-1015, 2000 | 3835 | 2000 |
| SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021 | 3282 | 2021 |
| Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021 | 2577 | 2021 |
| Evolution of MRSA during hospital transmission and intercontinental spread SR Harris, EJ Feil, MTG Holden, MA Quail, EK Nickerson, N Chantratita, ... Science 327 (5964), 469-474, 2010 | 1282 | 2010 |
| Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance MTG Holden, EJ Feil, JA Lindsay, SJ Peacock, NPJ Day, MC Enright, ... Proceedings of the National Academy of Sciences 101 (26), 9786-9791, 2004 | 1228 | 2004 |
| Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study L García-Álvarez, MTG Holden, H Lindsay, CR Webb, DFJ Brown, ... The Lancet infectious diseases 11 (8), 595-603, 2011 | 1205 | 2011 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1109 | 2021 |
| Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis D Limmathurotsakul, N Golding, DAB Dance, JP Messina, DM Pigott, ... Nature microbiology 1 (1), 1-5, 2016 | 995 | 2016 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 972 | 2021 |
| Melioidosis WJ Wiersinga, BJ Currie, SJ Peacock New England Journal of Medicine 367 (11), 1035-1044, 2012 | 951 | 2012 |
| Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei MTG Holden, RW Titball, SJ Peacock, AM Cerdeño-Tárraga, T Atkins, ... Proceedings of the National Academy of Sciences 101 (39), 14240-14245, 2004 | 937 | 2004 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 845 | 2022 |
| Emergence and global spread of epidemic healthcare-associated Clostridium difficile M He, F Miyajima, P Roberts, L Ellison, DJ Pickard, MJ Martin, TR Connor, ... Nature genetics 45 (1), 109-113, 2013 | 839 | 2013 |
| How Clonal Is Staphylococcus aureus? EJ Feil, JE Cooper, H Grundmann, DA Robinson, MC Enright, T Berendt, ... Journal of bacteriology 185 (11), 3307-3316, 2003 | 816 | 2003 |
| Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus SJ Peacock, CE Moore, A Justice, M Kantzanou, L Story, K Mackie, ... Infection and immunity 70 (9), 4987-4996, 2002 | 810 | 2002 |
| Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak CU Köser, MTG Holden, MJ Ellington, EJP Cartwright, NM Brown, ... New England Journal of Medicine 366 (24), 2267-2275, 2012 | 792 | 2012 |
| SARS-CoV-2 variant biology: immune escape, transmission and fitness AM Carabelli, TP Peacock, LG Thorne, WT Harvey, J Hughes, SJ Peacock, ... Nature Reviews Microbiology 21 (3), 162-177, 2023 | 775 | 2023 |
| Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study JM Bryant, DM Grogono, D Greaves, J Foweraker, I Roddick, T Inns, ... The Lancet 381 (9877), 1551-1560, 2013 | 768 | 2013 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 752 | 2021 |
Nicholas P J DayProfessor of Tropical Medicine, University of OxfordVerified email at ndm.ox.ac.uk